Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 435

2.

Perception and documentation of arrhythmias after successful radiofrequency catheter ablation of accessory pathways.

Oddsson H, Walfridsson H, Edvardsson N.

Ann Noninvasive Electrocardiol. 2001 Jul;6(3):216-21.

PMID:
11466140
3.

Challenging the superiority of amiodarone for rate control in Wolff-Parkinson-White and atrial fibrillation.

Simonian SM, Lotfipour S, Wall C, Langdorf MI.

Intern Emerg Med. 2010 Oct;5(5):421-6. doi: 10.1007/s11739-010-0385-6. Epub 2010 May 1. Review.

4.

Initiation of atrial fibrillation in the Wolff-Parkinson-White syndrome: the importance of the accessory pathway.

Wathen M, Natale A, Wolfe K, Yee R, Klein G.

Am Heart J. 1993 Mar;125(3):753-9.

PMID:
8438704
5.

Clinical presentation and treatment of atrial fibrillation in Wolff-Parkinson-White syndrome.

Thanavaro JL, Thanavaro S.

Heart Lung. 2010 Mar-Apr;39(2):131-6. doi: 10.1016/j.hrtlng.2009.06.011. Epub 2009 Aug 25.

PMID:
20207273
6.
7.

[Treatment of supraventricular tachyarrhythmias: drugs or ablation?].

Chimienti M, Barbieri S.

G Ital Cardiol. 1996 Feb;26(2):213-26. Review. Italian. No abstract available.

PMID:
8666179
10.

Clinical and electrophysiologic effects of amiodarone in patients with atrial fibrillation complicating the Wolff-Parkinson-White syndrome.

Feld GK, Nademanee K, Stevenson W, Weiss J, Klitzner T, Singh BN.

Am Heart J. 1988 Jan;115(1 Pt 1):102-7.

PMID:
3336964
11.

Paroxysmal atrial flutter and fibrillation associated with preexcitation syndrome: treatment with ajmaline.

Sclarovsky S, Kracoff OH, Strasberg B, Lewin RF, Agmon J.

Am J Cardiol. 1981 Nov;48(5):929-33.

PMID:
7304440
12.

[Risk of ventricular fibrillation in patients with Wolff-Parkinson White syndrome].

Bootsma M, van der Wall EE, Schalij MJ.

Ned Tijdschr Geneeskd. 2003 Apr 12;147(15):708-14. Dutch.

PMID:
12722534
13.

Enhanced accessory pathway conduction following intravenous amiodarone in atrial fibrillation. A case report.

Schützenberger W, Leisch F, Gmeiner R.

Int J Cardiol. 1987 Jul;16(1):93-5.

PMID:
3610399
14.
15.

Control of tachyarrhythmias associated with Wolff-Parkinson-White syndrome by amiodarone hydrochloride.

Rosenbaum MB, Chiale PA, Ryba D, Elizari MV.

Am J Cardiol. 1974 Aug;34(2):215-23. No abstract available.

PMID:
4843156
16.
17.

[Pre and Postoperative evaluation of the incidence of arrhythmia in patients undergoing corrective intervention for Ebstein anomaly].

Brancaccio G, Chauvaud S, Carpentier A.

Ital Heart J Suppl. 2000 Sep;1(9):1173-9. Italian.

PMID:
11140286
18.

[Recurrent episodes of Morgagni-Adams-Stokes syndrome due to degeneration of atrio-ventricular tachycardias into atrial fibrillation in a patient with Wolf-Parkinson-White syndrome].

Walczak F, Biederman A, Jodkowska M, Jedynak Z, Rembelska H, Kepski R, Sliwiński M, Hoffman M.

Kardiol Pol. 1991;34(6):364-6. Polish.

PMID:
1942747
19.

Amiodarone in long term management of refractory cardiac tachyarrhythmias.

Lubbe WF, Mercer CJ, Roche AH, Lowe JB.

N Z Med J. 1981 Jan 28;93(676):31-5.

PMID:
6940024
20.

The role of the accessory pathway in the onset of atrial fibrillation in Wolff-Parkinson-White syndrome--electrophysiological examination before and after surgical ablation.

Tsuchioka Y, Karakawa S, Nagata K, Mukai J, Watanabe M, Yamagata T, Matsuura H, Kajiyama G, Matsuura Y.

Jpn Circ J. 1994 Feb;58(2):95-9.

PMID:
8196160

Supplemental Content

Support Center